Unusual Multiorgan Immunoglobulin G4 (IgG4) Inflammation: Autoimmune Pancreatitis, Mikulicz Syndrome, and IgG4 Mastitis
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Autoimmune pancreatitis (AIP) type 1 is commonly associated with simultaneous involvement of extrapancreatic organs. Sclerosing cholangitis, sialadenitis, retroperitoneal fibrosis, Sjögren syndrome, and other extrapancreatic lesions are often observed concurrently with AIP. High levels of immunoglobulin G4 (IgG4) in the blood serum and affected tissues are typical of this diagnostic entity. We describe a case report of a 58-year-old female with findings of AIP (according to Asian criteria), IgG4-positive mastitis, and histologically verified Mikulicz syndrome. The effect of corticoid therapy supported the diagnosis of AIP and simultaneously led to the eradication of recurrent mastitis. To the best of our knowledge,this is the first reported case of concurrent findings of AIP and IgG4 mastitis. Our case report supports the concept of systemic IgG4 syndrome with multisystem involvement. Timely diagnosis and appropriate therapy can be effective in a high percentage of patients.
Abstract
Autoimmune pancreatitis (AIP) type 1 is commonly associated with simultaneous involvement of extrapancreatic organs. Sclerosing cholangitis, sialadenitis, retroperitoneal fibrosis, Sjögren syndrome, and other extrapancreatic lesions are often observed concurrently with AIP. High levels of immunoglobulin G4 (IgG4) in the blood serum and affected tissues are typical of this diagnostic entity. We describe a case report of a 58-year-old female with findings of AIP (according to Asian criteria), IgG4-positive mastitis, and histologically verified Mikulicz syndrome. The effect of corticoid therapy supported the diagnosis of AIP and simultaneously led to the eradication of recurrent mastitis. To the best of our knowledge,this is the first reported case of concurrent findings of AIP and IgG4 mastitis. Our case report supports the concept of systemic IgG4 syndrome with multisystem involvement. Timely diagnosis and appropriate therapy can be effective in a high percentage of patients.
참고문헌 (27)
- Sarles H, "Chronic inflammatory sclerosis of the pancreas: an autonomous pancreatic disease?", Am J Dig Dis, 6, pp.688~698 (1961)
- Yoshida K, "Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis", Dig Dis Sci, 40, pp.1561~1568 (1995)
- Park DH, "Recent advances in autoimmune pancreatitis", Gut, 58, pp.1680~1689 (2009)
- Sugumar A, "Lymphoplasmacytic sclerosing pancreatitis (LPSP) and idiopathic duct centric pancreatis (IDCP) are distinct clinical forms of autoimmune pancreatitis (AIP)", Pancreas, 37, pp.497~ (2008)
- Kawaguchi K, "Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas", Hum Pathol, 22, pp.387~395 (1991)
- Kamisawa T, "Autoimmune pancreatitis is a systemic autoimmune disease", Am J Gastroenterol, 98, pp.2811~2812 (2003)
- Kamisawa T, "Autoimmune pancreatitis associated with retroperitoneal fibrosis", JOP, 6, pp.260~263 (2005)
- Takahashi N, "Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings", Radiology, 242, pp.791~801 (2007)
- Kamisawa T, "Close correlation between chronic sclerosing sialadenitis and immunoglobulin G4", Intern Med J, 36, pp.527~529 (2006)
- Kamisawa T, "IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy", Pancreatology, 6, pp.132~137 (2006)
- Sugumar A, "Autoimmune pancreatitis: pathologic subtypes and their implications for its diagnosis", Am J Gastroenterol, 104, pp.2308~2310 (2009)
- Frulloni L, "Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients", Am J Gastroenterol, 104, pp.2288~2294 (2009)
- Kamisawa T, "A new clinicopathological entity of IgG4-related autoimmune disease", J Gastroenterol, 38, pp.982~984 (2003)
- Deshpande V, "Autoimmune pancreatitis: a systemic immune complex mediated disease", Am J Surg Pathol, 30, pp.1537~1545 (2006)
- Deheragoda MG, "The use of immunoglobulin g4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis", Clin Gastroenterol Hepatol, 5, pp.1229~1234 (2007)
- Kamisawa T, "Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease", J Gastroenterol, 41, pp.613~625 (2006)
- Watson SJ, "Nephropathy in IgG4-related systemic disease", Am J Surg Pathol, 30, pp.1472~1477 (2006)
- Hirano K, "High-rate pulmonary involvement in autoimmune pancreatitis", Intern Med J, 36, pp.58~61 (2006)
- Tsushima K, "Pulmonary involvement of autoimmune pancreatitis", Eur J Clin Invest, 39, pp.714~722 (2009)
- "Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis", Journal Of Gastroenterology, 43, pp.403~408 (2008)
- Chari ST, "Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic’s HISORt criteria", J Gastroenterol, 18(42 Suppl 18), pp.39~41 (2007)
- Cheuk W, "IgG4-related sclerosing mastitis: description of a new member of the IgG4-related sclerosing diseases", Am J Surg Pathol, 33, pp.1058~1064 (2009)
- Park do H, "Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis", Gastroenterology, 134, pp.440~446 (2008)
- Chari ST, "Current concepts in the treatment of autoimmune pancreatitis", JOP, 8, pp.1~3 (2007)
- Sandanayake NS, "Presentation and management of post-treatment relapse in autoimmune pancreatitis", immunoglobulin G4-associated cholangitis, 2009, pp.7, 1089~1096
- Kamisawa T, "Therapeutic strategy for autoimmune pancreatitis", Adv Med Sci, 53, pp.145~148 (2008)
- Kamisawa T, "Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome", Scand J Gastroenterol, 43, pp.609~613 (2008)